RWD132 Retrospective Analysis of the Trends in Adverse Event Reporting for BRAF Inhibitors, MEK Inhibitors, and Immune Checkpoint Inhibitors from 2012-2021
| Autor: | Mullins, K |
|---|---|
| Zdroj: | In Value in Health July 2022 25(7) Supplement:S601-S602 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect